ASN95 -- Selected abstracts: IGA Nephropathy

Sun. Nov. 5 1995

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Determination of progression

Program number 95 Board# S95 at 10:45 A.M.
* Predictive evaluation of long-term prognosis in individual IGA nephropathy patients. Y. Kobayashi, T. Kokubo, A.Horii, Y. Hiki and S. Tateno. - Sagamihara, Japan.

Program number 96 Board# S96 at 10:45 A.M.
* Does the a1166c polymorphism in the angiotensin type 1 receptor gene have an influence on the progression to renal failure? H. Yoshida, A. Hamaguchi, M. Shimoda, T. Eto, T. Kawamura, T. Hunley, V. Kon, T. Mitarai and O. Sakai. - Tokyo, Japan and Nashville, TN.

Program number 97 Board# S97 at 10:45 A.M.
* The impact ofthe ACE gene polymorphism on the slowly progressive IGA nephropathy may be linked to the glomerular size. M. Ogura, H. Yoshida, T. Kawamura, A. Hamaguchi, Y. Miyazaki, T. Mitarai, T. Okada, T. Eto, T. Kitajima and O. Sakai. - Tokyo, Japan.

Program number 100 Board# S100 at 10:45 A.M.
* Sodium-dependency of urinary protein excretion: A proposed clinical parameter for intrarenal angiotensin, and a predictor for the antiproteinuric response to angiotensin-converting enzyme inhibition in hypertensive IGA nephropathy patients. T. Kawamura, H. Yoshida, A. Hamaguchi, Y. Utsunomiya, A. Abe, T. Mitarai, I. Ichikawa and O. Sakai. - Tokyo and Saitama, Japan and Nashville, TN.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
IGA nephropathy

Program number 115 Board# S115 at 10:45 A.M.
* Effect of treatment with ACE inhibitor on TGF-beta gene expressions in renal biopsy from patients with IGA nephropathy. M. Nishimura, M. Okamura, Y. Konishi, K. Inoue, C.K. Young, T. Yoshioka, N. Negoro, T. Inoue and Y.Kanayama. - Osaka, Japan.

Program number 121 Board# S121 at 10:45 A.M.
* An artificial neural network can select patients at high risk of developing progressive IGA nephropathy more accurately than experienced nephrologists. C.C. Geddes, J.G. Fox, M.E.M. Allison, J.M. Boulton-Jones and K. Simpson. - Glasgow, United Kingdom.

Program number 122 Board# S122 at 10:45 A.M.
* Genetic polymorphism of renin-angiotensin system in progressive IGA nephropathy. Y. Pei, J.W. Scholey, K. Thai, B.T. Kua, W. Chan, L. Ibels and D. Cattran. - Toronto, Canada and New South Wales, Australia.

Program number 124 Board# S124 at 10:45 A.M.
* Early intensive therapy for IGA nephropathy: A five-year follow-up study. O. Hotta, Y. Taguma, T. Oda, J. Nishiyama, N. Yusa, S. Chiba, I. Horigome, K. Sudo and N. Yoshizawa. - Sendai and Saitama, Japan.

Program number 125 Board# S125 at 10:45 A.M.
* Beta-microglobulin as an indicator of interstitial cell infiltration in IGA nephropathy. T. Tsutsui, K. Nitta, H. Ozu, T. Naito, A. Kawashima, S. Horita, W. Yumura and H. Nihei. - Tokyo, Japan.

Program number 126 Board# S126 at 10:45 A.M.
* IGA nephropathy: Multivariate analysis of risk factors of end stage renal failure in a prospective cohort. L. Frimat, S. Briancon, D. Hestin, T. Cao Huu and M. Kessler. - Nancy, France.

Mon. Nov. 6 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hypertension: Clinical i

Program number 787 Board# M56 at 10:00 A.M.
* A family history of hypertension is associated to nephrosclerosis and predicts the future onset of hypertension in patients with IGA nephropathy. P. Simon, R. Boulahrouz, V. Autuly, C. Charasse and P. Le Cacheux, K.S. Ang and M.P. Ramee. - St. Brieuc, France.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
ANCA

Program number 943 Board# M212 at 10:00 A.M.
* De novo mesangial IGA nephropathy in patients with Wegener's granulomatosis and pauci-immune crescentic glomerulonephritis. K. Andrassy, R. Waldherr, M. Zeier and E. Ritz. - Heidelberg, Germany.

Program number 944 Board# M213 at 10:00 A.M.
* Serum IGA reacting with neutrophil cytoplasmic antigens in henoch-schoenlein nephritis: Evidences of a non-immune binding based on carbohydrate interactions. R. Coppo. - Torino, Italy.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Basic immunology: Fibroinflammatory responses

Program number 1097 Board# M366 at 10:00 A.M.
* Abnormal glycation of n-linked residues in serum IGA of patients with IGA nephropathy. R. Coppo, P. Cirina, P. Brusa, A. Amore, L.Peruzzi, B. Gianoglio and L. Cattel. - Torino, Italy.

4:00 P.M. ---Free Communications--- San Diego Conv Ctr Rm 3
Glomerular syndromes

Program number 1386 at 5:45
* Predicting outcome in IGA nephropathy. M.G. Radford Jr., J.V. Donadio Jr. and J.P.Grande. - Rochester, MN.

Tue. Nov. 7 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Electrolyte and acid-base disorders

Program number 1497 Board# T47 at 10:00 A.M.
* Renal potassium and acid-base regulating capacity of children with IGA nephropathy with moderate renalinsufficiency. Y.Komatsu, H. Shiraga, M. Nagata, Y. Tsunoda, H. Kawaguchi and K. Ito. - Tokyo,Japan.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Clinical transplantation I

Program number 1822 Board# T372 at 10:00 A.M.
* Persistent or transient deposition of IGA in kidney allografts: Impact on long term graft survival. L.W. Gaber, M. Polar, L.W. Moore and A.O. Gaber. - Memphis, TN.

Wed. Nov. 8 1995

10:00 A.M. ---Free Communications--- San Diego Conv Ctr Rm 4
Renin angiotensin system: Polymorphism and renal disease

Program number 2254 at 11:45
* Polymorphism of angiotensin converting enzyme, but not angiotensinogen or angiotensin type 1 receptor genes predicts progressive renal damage in IGA nephropathy. T.E. Hunley, B.A. Julian, J.A. Phillips, H. Yoshida, R.G. Horn, N.J. Brown, I. Ichikawa and V. Kon. - Nashville, TN; Birmingham, AL and Tokyo, Japan.

Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.